Skye Bioscience (SKYE) Stock: Buy, Sell, or Hold?
SKYE - Skye Bioscience, Inc. Common Stock
$1.68
0.08 (5.00%)
▲
5d:
+0.6%
30d:
-8.7%
90d:
+138.87%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When SKYE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SKYE is currently trading at $1.68, which is considered slightly low relative to its 30-day fair value range of $1.63 to $1.98.
Technical Outlook: Technically, SKYE is in a strong uptrend. Immediate support is located at $1.53, while resistance sits at $1.95. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $68.00 (+3947.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SKYE is in a strong uptrend. Immediate support is located at $1.53, while resistance sits at $1.95. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $68.00 (+3947.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.63 -
$1.98
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 3947.6% below Wall St target ($68.00)
- NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$1.63 -
$1.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.53
Resistance Level
$1.95
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.23
Wall Street Target
$68.00
(+3947.6%)
Share & Embed Analysis
Last updated: October 04, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKYE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 65 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 68 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$128 | 56 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
19 analysts |
$18 | 52 HOLD |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$41 | 60 BUY |
